| Literature DB >> 26712447 |
Usiakimi Igbaseimokumo1, Sittana El Shafie, Abdul Latif Al Khal.
Abstract
Entities:
Mesh:
Substances:
Year: 2016 PMID: 26712447 PMCID: PMC4797532 DOI: 10.4103/0366-6999.172609
Source DB: PubMed Journal: Chin Med J (Engl) ISSN: 0366-6999 Impact factor: 2.628
Figure 1Axial T1-weighted postcontrast magnetic resonance imaging scan ring enhancing lesion at presentation (a) and 4 weeks after treatment (b).
Drug susceptibility of Nocardia crassostreae isolated from the patient (Etest, AB Biodisc, Solna, Sweden)
| Antimicrobial agent | Susceptibility |
|---|---|
| Penicillin G | S |
| Amoxicillin | S |
| Co-amoxiclav | S |
| Mezlocillin | S |
| Piperacillin | S |
| Cefaclor | S |
| Cefuroxime | S |
| Cefuroxime axetil | S |
| Imipenem | S |
| Meropenem | S |
| Gentamicin | I |
| Tobramycin | I |
| Netilmicin | I |
| Amikacin | I |
| Ciprofloxacin | S |
| Ofloxacin | S |
| Levofloxacin | S |
| Tetracycline | S |
| Doxycycline | S |
| Erythromycin | S |
| Clindamycin | R |
| Vancomycin | R |
| Teicoplanin | R |
S: Susceptible; I: Intermediate; R: Resistant.